CompletedPhase 3ACTRN12608000235303
Topical capsaicin in burning mouth syndrome
The efficacy of topical capsaicin in reducing symptoms in patients with burning mouth syndrome
Sponsor
Sao Paulo University
Enrollment
20 participants
Start Date
Dec 10, 2007
Study Type
Interventional
Conditions
Eligibility
Sex: Both males and females
Plain Language Summary
Simplified for easier understanding
This study is looking at topical capsaicin in burning mouth syndrome. It is open to both men and women, who burning mouth syndrome, no recent use of other drugs. People with certain health conditions such as diabetic patients, anemia, candida infection may not be able to join. If you take part, the research team will explain what is involved and monitor your health throughout the study.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Patients will be instructed to apply topical capsaicin 0.075%, twice a day (middle morning and middle afternoon) for 8 weeks with a one-week interval - the fourth.
Patients will be instructed to apply topical capsaicin 0.075%, twice a day (middle morning and middle afternoon) for 8 weeks with a one-week interval - the fourth.
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12608000235303